+91 96866 96505
/
080 222 400 34
info@oncostemdiagnostics.com
About Us
Leadership
Clinical Advisors
Awards and Recognition
CanAssist Breast
About CanAssist Breast
Science and Validation
How it works
Sample Report
Understand your risk score
Testimonials
FAQs
Media
Media Mentions
Videos
Newsletter
Resources
Insurance Reimbursement
Brochures
Scientific Publications
Testimonials
Blog
Contact Us
Contact Us
Request Free
Counselling
Careers
OncoStem
CanAssist Breast
Resources
Scientific Publications
Book your test
Scientific Publications
Sengupta, A., et al (2020). Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX. Cancer Medicine. doi: 10.1002/cam4.3495
Patil, P., et al. (2020). CanAssist breast: An affordable breast cancer prognostic test validated on Asian patients. doi: 10.1200/JCO.2020.38.15_suppl.541
Krishnamurthy A (2020). Breast cancer prognostic tools: A promising Indian option. Int J Mol Immuno Oncol 2020;5(2):47-8. doi: 10.25259/IJMIO_15_2020
Bhattacharyya, G. S., et al. (2020). Overview of Breast Cancer and Implications of Overtreatment of Early-Stage Breast Cancer: An Indian Perspective. JCO Global Oncology, 6, 789-798. doi: 10.1200/GO.20.00033
Sankaran, S., et al. (2019). CanAssist Breast impacting clinical treatment decisions in early-stage HR+ breast cancer patients: Indian scenario. Indian Journal of Surgical Oncology, 1-9. doi: 0.1007/s13193-019-01014-4
Bakre, M. (2019). 242P Clinical validation of CanAssist breast in a Spanish cohort. Annals of Oncology, 30(Supplement_5), mdz240-066. doi: 10.1093/annonc/mdz240.066
Gopalakrishnan, V., et al. (2019). Impact of CanAssist-Breast in clinical treatment decisions in early stage HR+ breast cancer patients: Asian Scenario. Journal of Global Oncology 5, no. suppl (October 07, 2019) 109-109. doi: 10.1200/JGO.2019.5.suppl
Bakre, M. M., et al. (2019). Clinical validation of an immunohistochemistry-based CanAssist Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients.Cancer medicine 1-10. doi: 10.1002/cam4.2049
Attuluri., A. K., et al (2019). Analytical Validation of the immunohistochemistry-based CanAssist Breast Prognostic Test for Prediction of Risk of Recurrence in Hormone Receptor- Positive Breast Cancer. BMC Cancer 19:249. doi: 10.1186/s12885-019-5443-5
Ramkumar, C., et al. (2018). Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor–Positive Breast Cancer. Biomarker insights, 13, 1177271918789100. doi: 10.1177/1177271918789100
Prakash, C., et al. (2018). Risk stratification in early-stage estrogen receptor+ /HER2-breast cancer patients: Comparative analysis of cost-effective methods
Bakre, M. (2018). 4P CanAssist-Breast-an immunohistochemistry based test for risk of recurrence prediction for early stage breast cancer patients: A cost-effective and accurate solution for Asia. Annals of Oncology, 29(suppl_9), mdy426-003. doi: 10.1093/annonc/mdy426.003
Somashekhar, S., et al. (2017). 1675P Risk of recurrence prediction and optimum treatment planning for early-stage breast cancer patients: A cost-effective, accurate and broad based solution for Asia
Ramkumar, C., et al. (2017). Assessment of Ki67 As a Prognostic Marker in Hormone Receptor Positive Breast Cancer: A Retrospective Study
Want to know about your recurrence risk?
to personalize your cancer treatment and reduce the risk & side effects of chemotheraphy
BOOK YOUR TEST